CUSIP: 00654J206
What is CUSIP 00654J206?
CUSIP 00654J206 identifies ADXN - Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares in SEC 13F datasets.
Where can I see the latest institutional holders?
Review the Q4 2025 holders report and the ownership history table below.
Open recent reporting periods for CUSIP 00654J206:
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Dyer Timothy Mark | 13% | $153,679,208 | 18,208,437 | Timothy Mark Dyer | 20 Jun 2025 |
As of 31 Dec 2025, 5 institutional investors reported holding 610 shares of Addex Therapeutics Ltd. - American Depositary Shares, each representing 120 ordinary shares Ordinary shares (ADXN). This represents 0% of the company’s total 140,714,351 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q4 | 610 | $4,707 | +$3,171 | $7.72 | 5 |
| 2025 Q3 | 199 | $1,855 | -$1,631 | $9.25 | 4 |
| 2025 Q2 | 377 | $3,463 | -$95,571 | $9.40 | 5 |
| 2025 Q1 | 13,111 | $96,235 | -$14,614 | $7.34 | 5 |
| 2024 Q4 | 15,102 | $105,714 | +$93,193 | $7.00 | 5 |
| 2024 Q3 | 1,388 | $13,556 | -$9,893 | $9.77 | 3 |
| 2024 Q2 | 2,400 | $19,728 | +$16,522 | $8.22 | 2 |
| 2024 Q1 | 390 | $4,992 | -$712,034 | $12.80 | 1 |
| 2023 Q4 | 159,827 | $717,026 | +$565,878 | $6.05 | 3 |